To die or not to die - The quest of the TRAIL receptors

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

The last 18 months have witnessed the characterization of several new members of the tumor necrosis factor (TNF) receptor family. Among these are five receptors for the cytotoxic ligand TRAIL (TNF-related apoptosis-inducing ligand). Two of these receptors, TRAIL-R1 and TRAIL-R2, contain classical cytoplasmic death domains and are able to transduce an apoptotic signal. The others lack functional death domains and are not able to promote cell death. Indeed, one of the receptors for TRAIL, osteoprotegerin (OPG) is a soluble protein whose activities so far have been shown to be inhibition of osteoclastogenesis and increased bone density in vivo. The existence of multiple receptors for TRAIL suggests an unexpected complexity to TRAIL- mediated biological functions.

Original languageEnglish
Pages (from-to)535-542
Number of pages8
JournalJournal of leukocyte biology
Volume65
Issue number5
DOIs
Publication statusPublished - 1 Jan 1999
Externally publishedYes

Keywords

  • Apoptosis
  • Death receptor
  • NF-≃B tumor necrosis factor

Cite this

@article{b64ec55019e34ff09e5001b6ae6dc5ea,
title = "To die or not to die - The quest of the TRAIL receptors",
abstract = "The last 18 months have witnessed the characterization of several new members of the tumor necrosis factor (TNF) receptor family. Among these are five receptors for the cytotoxic ligand TRAIL (TNF-related apoptosis-inducing ligand). Two of these receptors, TRAIL-R1 and TRAIL-R2, contain classical cytoplasmic death domains and are able to transduce an apoptotic signal. The others lack functional death domains and are not able to promote cell death. Indeed, one of the receptors for TRAIL, osteoprotegerin (OPG) is a soluble protein whose activities so far have been shown to be inhibition of osteoclastogenesis and increased bone density in vivo. The existence of multiple receptors for TRAIL suggests an unexpected complexity to TRAIL- mediated biological functions.",
keywords = "Apoptosis, Death receptor, NF-≃B tumor necrosis factor",
author = "Mariapia Degli-Esposti",
year = "1999",
month = "1",
day = "1",
doi = "10.1002/jlb.65.5.535",
language = "English",
volume = "65",
pages = "535--542",
journal = "Journal of leukocyte biology",
issn = "0741-5400",
publisher = "Society for Leukocyte Biology",
number = "5",

}

To die or not to die - The quest of the TRAIL receptors. / Degli-Esposti, Mariapia.

In: Journal of leukocyte biology, Vol. 65, No. 5, 01.01.1999, p. 535-542.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - To die or not to die - The quest of the TRAIL receptors

AU - Degli-Esposti, Mariapia

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The last 18 months have witnessed the characterization of several new members of the tumor necrosis factor (TNF) receptor family. Among these are five receptors for the cytotoxic ligand TRAIL (TNF-related apoptosis-inducing ligand). Two of these receptors, TRAIL-R1 and TRAIL-R2, contain classical cytoplasmic death domains and are able to transduce an apoptotic signal. The others lack functional death domains and are not able to promote cell death. Indeed, one of the receptors for TRAIL, osteoprotegerin (OPG) is a soluble protein whose activities so far have been shown to be inhibition of osteoclastogenesis and increased bone density in vivo. The existence of multiple receptors for TRAIL suggests an unexpected complexity to TRAIL- mediated biological functions.

AB - The last 18 months have witnessed the characterization of several new members of the tumor necrosis factor (TNF) receptor family. Among these are five receptors for the cytotoxic ligand TRAIL (TNF-related apoptosis-inducing ligand). Two of these receptors, TRAIL-R1 and TRAIL-R2, contain classical cytoplasmic death domains and are able to transduce an apoptotic signal. The others lack functional death domains and are not able to promote cell death. Indeed, one of the receptors for TRAIL, osteoprotegerin (OPG) is a soluble protein whose activities so far have been shown to be inhibition of osteoclastogenesis and increased bone density in vivo. The existence of multiple receptors for TRAIL suggests an unexpected complexity to TRAIL- mediated biological functions.

KW - Apoptosis

KW - Death receptor

KW - NF-≃B tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0032942436&partnerID=8YFLogxK

U2 - 10.1002/jlb.65.5.535

DO - 10.1002/jlb.65.5.535

M3 - Review Article

VL - 65

SP - 535

EP - 542

JO - Journal of leukocyte biology

JF - Journal of leukocyte biology

SN - 0741-5400

IS - 5

ER -